US Stock MarketDetailed Quotes

ARTL Artelo Biosciences

Watchlist
  • 1.2200
  • +0.1800+17.31%
Close Nov 18 16:00 ET
  • 1.1500
  • -0.0700-5.74%
Post 20:01 ET
3.94MMarket Cap-425P/E (TTM)

About Artelo Biosciences Company

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.

Company Profile

SymbolARTL
Company NameArtelo Biosciences
Listing DateJun 21, 2019
Founded2011
CEOMr. Gregory D. Gorgas
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address505 Lomas Santa Fe,Suite 160
CitySolana Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92075
Phone1-858-925-7049
Websitehttp://www.artelobio.com

Company Executives

  • Name
  • Position
  • Salary
  • Gregory D. Gorgas
  • Director, President, Chief Executive Officer, Secretary, Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 994.10K
  • Connie L. Matsui
  • Chairman of the Board
  • 74.41K
  • Dr. Douglas Blayney, M.D.
  • Independent Director
  • 45.91K
  • Tamara A. Favorito
  • Independent Director
  • 55.80K
  • Steven Kelly
  • Independent Director
  • 57.41K
  • Dr. R. Martin Emanuele, PhD
  • Independent Director
  • 36.91K
  • Dr. Gregory R. Reyes, M.D.,PhD
  • Independent Director
  • 42.41K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data